LOX and cardiac hypertrophy: More interestingly, LOX transgenesis exacerbated the cardiac hypertrophy and dysfunction induced by the chronic infusion of Angiotensin II (Ang II) (Figure 5A), triggering a more severe fibrotic process with higher collagen deposition and CCL (Figure 5B) and an enhanced expression of fibrotic markers.